Logo

American Heart Association

  57
  0


Final ID: MP2234

Trends in Nonalcoholic Steatohepatitis and Congestive Heart Failure Mortality in the United States from 1999 to 2020: A Comprehensive Analysis

Abstract Body (Do not enter title and authors here):

Background:
Metabolic-dysfunction associated steatohepatitis (MASH), previously nonalcoholic steatohepatitis (NASH), and congestive heart failure (CHF) are rising public health concerns in the U.S. This study evaluates trends in age-adjusted mortality rates (AAMR) for NASH and CHF from 1999 to 2020.

Methods:
CHF-related deaths in patients with pre-existing NASH from 1999 to 2020 were obtained from the CDC WONDER database. AAMR per million population were calculated. Trends were analyzed using average annual percentage change (AAPC) and joinpoint regression.
Results:
From 1999 to 2020, NASH and CHF caused 68,436 deaths in the U.S. AAMR increased from 12.49 per million (95% CI 11.97-13.01) in 1999 to 29.25 per million (95% CI 23.71-24.9) in 2020. Mortality rates declined from 1999 to 2010 (APC -1.49; 95% CI -2.23 to -0.89, p=0.003) but surged from 2017 to 2020 (APC 12.35; 95% CI 9.70-15.98, p=0.010). The overall AAPC was 3.05% (95% CI 2.79-3.30, p<0.0001).

Conclusion:
This analysis shows a concerning increase in NASH and CHF-related mortality in recent years. The rise in mortality highlights the need for targeted clinical interventions and public health strategies to mitigate the burden of these diseases.
  • Plunkett, Ryan  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Ahmed, Faizan  ( Duke University Hospital , Durham , North Carolina , United States )
  • Philip, Nicholas  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Taha, Isra  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Desai, Nitin  ( Saint Louis University , Saint Louis , Missouri , United States )
  • Stein, Eric  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Thomas, Alexander  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Rotramel, Hayden  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Raja Sager, Avinaash  ( Boston Medical Center , Boston , Massachusetts , United States )
  • Bedi, Rohil  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Golemi, Lolita  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Khorsandi, Michael  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Peters, John  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Okeke, Barbara  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Rogers, Lanerica  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Rojulpote, Chaitanya  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Mikhalkova, Deana  ( Saint Louis University , Saint Louis , Missouri , United States )
  • Qureshi, Kamran  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Lin, Chien-jung  ( Saint Louis University Hospital , Saint louis , Missouri , United States )
  • Author Disclosures:
    ryan plunkett: No Answer | Rohil Bedi: DO NOT have relevant financial relationships | Lolita Golemi: No Answer | Michael Khorsandi: No Answer | John Peters: No Answer | Barbara Okeke: No Answer | Lanerica Rogers: DO NOT have relevant financial relationships | Chaitanya Rojulpote: DO NOT have relevant financial relationships | Deana Mikhalkova: No Answer | Kamran Qureshi: No Answer | Chien-Jung Lin: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Boston Scientific:Past (completed) | Faizan Ahmed: DO NOT have relevant financial relationships | Nicholas Philip: DO NOT have relevant financial relationships | Isra Taha: DO NOT have relevant financial relationships | Nitin Desai: DO NOT have relevant financial relationships | Eric Stein: DO NOT have relevant financial relationships | Alexander Thomas: No Answer | Hayden Rotramel: No Answer | Avinaash Raja Sager: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Heart Failure in CKM Syndrome: Prevention, Management and Outcomes

Monday, 11/10/2025 , 01:45PM - 02:55PM

Moderated Digital Poster Session

More abstracts on this topic:
GLP-1 Receptor Agonist Semaglutide Improves Hepatic Metabolism and Reverses Hepatic Steatosis Independent of Weight Loss in Cardiometabolic HFpEF

Gehred Natalie, Allerton Timothy, Goodchild Traci, Lefer David, Vondriska Thomas, Gromova Tatiana, Elbatreek Mahmoud, Li Zhen, Chen Jingshu, Muraoka Naoto, Borch Jensen Martin, Kartha Vinay, Carrico Chris

Liver Steatosis and Liver Fibrosis Predict Major Adverse Cardiovascular Events in the CLEAR Outcomes Trial

De Jong Vivian, Grobbee Diederick, Saidi Alina, Castro Cabezas Manuel, Nissen Steven, Sasiela William, Li Na, Bloedon Leanne, Lincoff Abraham, Nicholls Stephen

More abstracts from these authors:
Clinical Characteristics, Survival Rates, and Prevalence of Cardiovascular Readmissions in Patients with Primary Malignant Cardiac Tumors

Anand Reddy Maligireddy, Rojulpote Chaitanya, Lin Chien-jung, Mikhalkova Deana, Frick William, Dickey Sierra, Sinha Shrishti, Okeke Barbara, Chitturu Niteesh, Golemi Lolita, Bandaru Revanth Reddy, Khan Sumrah

Trends in-hospital mortality and 90-day outcomes in cardiac implantable electronic device management amongst patients with and without ERSD, a national analysis

Anand Reddy Maligireddy, Lin Chien-jung, Mikhalkova Deana, Ierovante Nicholas, Mar Philip, Golemi Lolita, Rojulpote Chaitanya, Frick William, Ghosh Somshukla, Siebert Jason, Khan Ali, Saraf Rabya, Patil Shivaraj

You have to be authorized to contact abstract author. Please, Login
Not Available